Travis J Hollmann
Overview
Explore the profile of Travis J Hollmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
4977
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moorman A, Benitez E, Cambuli F, Jiang Q, Mahmoud A, Lumish M, et al.
Nature
. 2025 Jan;
637(8047):E28.
PMID: 39789339
No abstract available.
2.
Taube J, Sunshine J, Angelo M, Akturk G, Eminizer M, Engle L, et al.
J Immunother Cancer
. 2025 Jan;
13(1).
PMID: 39779210
Objectives: Multiplex immunohistochemistry and immunofluorescence (mIHC/IF) are emerging technologies that can be used to help define complex immunophenotypes in tissue, quantify immune cell subsets, and assess the spatial arrangement of...
3.
Moorman A, Moorman A, Benitez E, Benitez E, Cambuli F, Cambulli F, et al.
Nature
. 2024 Oct;
637(8047):947-954.
PMID: 39478232
As cancers progress, they become increasingly aggressive-metastatic tumours are less responsive to first-line therapies than primary tumours, they acquire resistance to successive therapies and eventually cause death. Mutations are largely...
4.
Tsimberidou A, Alayli F, Okrah K, Drakaki A, Khalil D, Kummar S, et al.
J Exp Med
. 2024 Aug;
221(10).
PMID: 39190534
Identifying pan-tumor biomarkers that predict responses to immune checkpoint inhibitors (ICI) is critically needed. In the AMADEUS clinical trial (NCT03651271), patients with various advanced solid tumors were assessed for changes...
5.
Pourmaleki M, Jones C, Mellinghoff S, Greenstein B, Kumar P, Foronda M, et al.
Clin Cancer Res
. 2024 Jul;
30(17):3881-3893.
PMID: 38949890
Purpose: Classic Hodgkin lymphoma (cHL) is a B-cell lymphoma that occurs primarily in young adults and, less frequently, in elderly individuals. A hallmark of cHL is the exceptional scarcity (1%-5%)...
6.
Rumberger J, Greenwald N, Ranek J, Boonrat P, Walker C, Franzen J, et al.
bioRxiv
. 2024 Jun;
PMID: 38895405
Multiplexed imaging offers a powerful approach to characterize the spatial topography of tissues in both health and disease. To analyze such data, the specific combination of markers that are present...
7.
Elkrief A, Waters N, Smith N, Dai A, Slingerland J, Aleynick N, et al.
Cancer Immunol Res
. 2023 Dec;
12(3):308-321.
PMID: 38108398
Colitis induced by treatment with immune-checkpoint inhibitors (ICI), termed irColitis, is a substantial cause of morbidity complicating cancer treatment. We hypothesized that abnormal fecal microbiome features would be present at...
8.
Vanguri R, Smithy J, Li Y, Zhuang M, Maher C, Aleynick N, et al.
J Pathol
. 2023 Sep;
261(3):349-360.
PMID: 37667855
As predictive biomarkers of response to immune checkpoint inhibitors (ICIs) remain a major unmet clinical need in patients with urothelial carcinoma (UC), we sought to identify tissue-based immune biomarkers of...
9.
Tagore M, Hergenreder E, Perlee S, Cruz N, Menocal L, Suresh S, et al.
Cancer Discov
. 2023 Aug;
13(10):2270-2291.
PMID: 37553760
Significance: This study shows evidence of GABA-mediated regulation of electrical activity between melanoma cells and keratinocytes, providing a new mechanism by which the microenvironment promotes tumor initiation. This provides insights...
10.
DeWolf S, Elhanati Y, Nichols K, Waters N, Nguyen C, Slingerland J, et al.
Sci Transl Med
. 2023 Jul;
15(706):eabq0476.
PMID: 37494469
T cells are the central drivers of many inflammatory diseases, but the repertoire of tissue-resident T cells at sites of pathology in human organs remains poorly understood. We examined the...